EyesoBio develops advanced pre-clinical screening platforms as alternatives to animal models for testing eye products. The company utilizes its cells-on-a-chip platform, coupled with time-lapse imaging, to rapidly evaluate product safety and efficacy. One of the main underlying problems in developing any new product is that a significant portion of R&D resources is also devoted to developing models to test them. The advanced models for pre-clinical testing from EyesoBio enable companies and academics to devote more of their R&D resources toward other key areas, such as product development.